{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:48:06Z","timestamp":1778658486424,"version":"3.51.4"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T00:00:00Z","timestamp":1390348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0086619","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T22:44:49Z","timestamp":1390430689000},"page":"e86619","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cyclophosphamide Alters the Gene Expression Profile in Patients Treated with High Doses Prior to Stem Cell Transplantation"],"prefix":"10.1371","volume":"9","author":[{"given":"Ibrahim","family":"El-Serafi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuchehr","family":"Abedi-Valugerdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Pot\u00e1cov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvaneh","family":"Afsharian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Moshfegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustapha","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,1,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.299.8.925","article-title":"Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases","volume":"299","author":"RK Burt","year":"2008","journal-title":"JAMA : the journal of the American Medical Association"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0609.1989.tb00305.x","article-title":"A comparison between regimens containing chemotherapy alone (busulfan and cyclophosphamide) and chemotherapy (V. RAPID) plus total body irradiation on marrow engraftment following allogeneic bone marrow transplantation","volume":"43","author":"M Reynolds","year":"1989","journal-title":"Eur J Haematol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0961203312469261","article-title":"Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil","volume":"22","author":"GM Daleboudt","year":"2013","journal-title":"Lupus"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000073353","article-title":"Ifosfamide and cyclophosphamide: effects on immunosurveillance","volume":"65","author":"G Binotto","year":"2003","journal-title":"Oncology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0163-7258(88)90004-6","article-title":"Metabolism of oxazaphosphorines","volume":"37","author":"NE Sladek","year":"1988","journal-title":"Pharmacology & therapeutics"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1124\/dmd.104.001107","article-title":"Haplotype structure and allele frequencies of CYP2B6 in a Korean population","volume":"32","author":"JY Cho","year":"2004","journal-title":"Drug Metabolism and Disposition"},{"key":"ref7","first-page":"5629","article-title":"Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes","volume":"53","author":"TK Chang","year":"1993","journal-title":"Cancer Res"},{"key":"ref8","first-page":"4229","article-title":"Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes","volume":"57","author":"S Ren","year":"1997","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejps.2005.08.008","article-title":"Pharmacogenetics of cyclophosphamide in patients with hematological malignancies","volume":"27","author":"H Xie","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/01213011-200512000-00004","article-title":"Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz","volume":"15","author":"K Klein","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01213011-200501000-00001","article-title":"Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients","volume":"15","author":"M Rotger","year":"2005","journal-title":"Pharmacogenetics and genomics"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bbrc.2004.05.116","article-title":"Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens","volume":"319","author":"K Tsuchiya","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Eroglu C, Pala C, Kaynar L, Yaray K, Aksozen MT, et al. (2013) Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant. Leuk Lymphoma.","DOI":"10.3109\/10428194.2013.779691"},{"key":"ref14","first-page":"167","article-title":"Gene expression profiling in acute myeloid leukaemia","volume":"69","author":"HJ de Jonge","year":"2011","journal-title":"The Netherlands journal of medicine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.2741\/3026","article-title":"Gene expression profiling for the diagnosis and prognosis of acute myeloid leukaemia","volume":"13","author":"K Mills","year":"2008","journal-title":"Front Biosci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.7314\/APJCP.2013.14.5.3223","article-title":"Association of immunohistochemically defined molecular subtypes with clinical response to presurgical chemotherapy in patients with advanced breast cancer","volume":"14","author":"S Khokher","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1182\/blood-2008-02-137372","article-title":"Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP","volume":"112","author":"LM Rimsza","year":"2008","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood.V81.4.1094.1094","article-title":"Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia","volume":"81","author":"O Ringden","year":"1993","journal-title":"Blood"},{"key":"ref19","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"D Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"E368","DOI":"10.1111\/ctr.12131","article-title":"A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors","volume":"27","author":"M Remberger","year":"2013","journal-title":"Clin Transplant"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng0193-77","article-title":"Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor\/CD3 complex immunodeficiency","volume":"3","author":"C Soudais","year":"1993","journal-title":"Nat Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nri2134","article-title":"CD3-specific antibodies: a portal to the treatment of autoimmunity","volume":"7","author":"L Chatenoud","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/dmrr.933","article-title":"Anti-CD3 mAbs for treatment of type 1 diabetes","volume":"25","author":"A Kaufman","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y","article-title":"A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells","volume":"29","author":"G Magistrelli","year":"1999","journal-title":"European journal of immunology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.270.5238.985","article-title":"Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4","volume":"270","author":"P Waterhouse","year":"1995","journal-title":"Science (New York, N Y )"},{"key":"ref26","article-title":"Genetic control of MHC class II expression","volume":"109","author":"JP Ting","year":"2002","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12026-009-8139-0","article-title":"High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation","volume":"47","author":"L Luznik","year":"2010","journal-title":"Immunol Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2012.44.3523","article-title":"T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation","volume":"31","author":"A Bashey","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/j.seminoncol.2012.09.005","article-title":"Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation","volume":"39","author":"L Luznik","year":"2012","journal-title":"Semin Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1126\/science.1144706","article-title":"A common fold mediates vertebrate defense and bacterial attack","volume":"317","author":"CJ Rosado","year":"2007","journal-title":"Science (New York, N Y )"},{"key":"ref31","first-page":"793","article-title":"Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B. Australian and New Zealand journal of medicine","volume":"25","author":"JA Trapani","year":"1995"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2012-07-446146","article-title":"Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack","volume":"121","author":"JA Lopez","year":"2013","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.4049\/jimmunol.166.3.1723","article-title":"Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2","volume":"166","author":"A Martino","year":"2001","journal-title":"Journal of Immunology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2172-14-39","article-title":"DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice","volume":"14","author":"J Cao","year":"2013","journal-title":"BMC Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4137\/CMO.S12268","article-title":"Influence of immunotherapy with autologous dendritic cells on innate and adaptive immune response in cancer","volume":"7","author":"BF Matias","year":"2013","journal-title":"Clin Med Insights Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1158\/0008-5472.CAN-11-3912","article-title":"Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective","volume":"72","author":"DT Le","year":"2012","journal-title":"Cancer Research"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1242\/jcs.01660","article-title":"The Ras superfamily at a glance","volume":"118","author":"K Wennerberg","year":"2005","journal-title":"J Cell Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/stem.170235","article-title":"The molecular perspective: the ras oncogene","volume":"17","author":"DS Goodsell","year":"1999","journal-title":"Stem Cells"},{"key":"ref39","first-page":"4682","article-title":"ras oncogenes in human cancer: a review","volume":"49","author":"JL Bos","year":"1989","journal-title":"Cancer Research"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood-2010-07-293357","article-title":"Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex","volume":"117","author":"K El Omari","year":"2011","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.4161\/cc.9.12.12074","article-title":"The thymus under siege: Lmo2 induces precancerous stem cells in a mouse model of T-ALL","volume":"9","author":"MP McCormack","year":"2010","journal-title":"Cell Cycle"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1182378","article-title":"The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal","volume":"327","author":"MP McCormack","year":"2010","journal-title":"Science (New York, N Y )"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-4781(98)00033-5","article-title":"MCM proteins: evolution, properties, and role in DNA replication","volume":"1398","author":"SE Kearsey","year":"1998","journal-title":"Biochimica et biophysica acta"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000073711","article-title":"Tuning of innate immunity and polarized responses by decoy receptors","volume":"132","author":"A Mantovani","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1158\/0008-5472.CAN-10-4523","article-title":"Unraveling cancer chemoimmunotherapy mechanisms by gene and protein expression profiling of responses to cyclophosphamide","volume":"71","author":"F Moschella","year":"2011","journal-title":"Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/geno.1999.5767","article-title":"Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1\/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q","volume":"57","author":"M Dale","year":"1999","journal-title":"Genomics"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1158\/1078-0432.CCR-12-3666","article-title":"Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients\u2019 blood cells: implications for cancer chemoimmunotherapy","volume":"19","author":"F Moschella","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood.V82.4.1110.1110","article-title":"Human FLT3\/FLK2 gene: cDNA cloning and expression in hematopoietic cells","volume":"82","author":"O Rosnet","year":"1993","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1172\/JCI64044","article-title":"Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility","volume":"123","author":"TC Kuo","year":"2013","journal-title":"The Journal of clinical investigation"},{"key":"ref50","first-page":"305","article-title":"Altered cJUN expression: an early event in human lung carcinogenesis","volume":"56","author":"E Szabo","year":"1996","journal-title":"Cancer Research"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1038\/sj.onc.1202989","article-title":"cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype","volume":"18","author":"LM Smith","year":"1999","journal-title":"Oncogene"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2407-7-145","article-title":"Critical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft model","volume":"7","author":"Y Zhang","year":"2007","journal-title":"BMC Cancer"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"44164","DOI":"10.1074\/jbc.M112.401521","article-title":"PAX2 protein induces expression of cyclin D1 through activating AP-1 protein and promotes proliferation of colon cancer cells","volume":"287","author":"HS Zhang","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.humpath.2006.01.022","article-title":"c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer","volume":"37","author":"MM Vleugel","year":"2006","journal-title":"Hum Pathol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1074\/jbc.M110.100792","article-title":"c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion","volume":"285","author":"X Jiao","year":"2010","journal-title":"J Biol Chem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/emboj\/18.1.188","article-title":"c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms","volume":"18","author":"R Wisdom","year":"1999","journal-title":"The EMBO journal"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1101\/gad.13.5.607","article-title":"Control of cell cycle progression by c-Jun is p53 dependent","volume":"13","author":"M Schreiber","year":"1999","journal-title":"Genes & development"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/blood-2010-07-299644","article-title":"c-JUN promotes BCR-ABL-induced lymphoid leukemia by inhibiting methylation of the 5\u2032 region of Cdk6","volume":"117","author":"K Kollmann","year":"2011","journal-title":"Blood"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0006-2952(94)90282-8","article-title":"Increased c-jun\/AP-1 levels in etoposide-resistant human leukemia K562 cells","volume":"48","author":"MK Ritke","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"ref60","first-page":"878","article-title":"cis-Diamminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway","volume":"52","author":"E Rubin","year":"1992","journal-title":"Cancer Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"39777","DOI":"10.1074\/jbc.M203927200","article-title":"Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine","volume":"277","author":"J Zhou","year":"2002","journal-title":"J Biol Chem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.onc.1210690","article-title":"Targeting c-Jun and JunB proteins as potential anticancer cell therapy","volume":"27","author":"EN Gurzov","year":"2008","journal-title":"Oncogene"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"19321","DOI":"10.1074\/jbc.M113.475442","article-title":"Differential Regulation of c-Jun Protein Plays an Instrumental Role in Chemoresistance of Cancer Cells","volume":"288","author":"Y Xia","year":"2013","journal-title":"Journal of Biological Chemistry"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0093239","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T00:00:00Z","timestamp":1395100800000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0086619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T13:25:13Z","timestamp":1597411513000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0086619"}},"subtitle":[],"editor":[{"given":"Antonio","family":"Perez-Martinez","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,22]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0086619","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0093239","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,22]]}}}